Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biocompatibility testing using ATP bioluminescence.

S P Crouch1

  • 1LumiTech Ltd, City Link, Nottingham, UK. s.crouch@lumitech.co.uk

Medical Device Technology
|February 24, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measurement of the ADP:ATP ratio in human leukaemic cell lines can be used as an indicator of cell viability, necrosis and apoptosis.

Journal of immunological methods·2000
Same author

Effects of r-metHuG-CSF on polymorphonuclear leucocyte kinetics and function in patients on continuous ambulatory peritoneal dialysis.

British journal of haematology·1998
Same author

Ex vivo neutrophil function in response to three different doses of glycosylated rHuG-CSF (Lenograstim).

British journal of haematology·1997
Same author

The effect of pregnancy on polymorphonuclear leukocyte function.

Journal of immunology (Baltimore, Md. : 1950)·1995
Same author

Primary and secondary granule release by polymorphonuclear leukocytes exposed to peritoneal dialysis effluent.

Clinical and diagnostic laboratory immunology·1994
Same author

The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity.

Journal of immunological methods·1993
Same journal

Safer arterial access.

Medical device technology·2010
Same journal

Building better surfaces.

Medical device technology·2010
Same journal

PVC: a broader perspective.

Medical device technology·2010
Same journal

Joining and forming using torsional ultrasonic principles.

Medical device technology·2010
Same journal

US regulation of combination products.

Medical device technology·2010
Same journal

Assessing biological safety of metals associated with medical devices.

Medical device technology·2010
See all related articles

Adenosine triphosphate bioluminescence offers a fast and sensitive method for biocompatibility screening, quickly assessing cell proliferation and toxicity. Measuring adenosine diphosphate further distinguishes between apoptosis and necrosis, enhancing cell death analysis.

Area of Science:

  • Biotechnology
  • Cell Biology
  • Toxicology

Background:

  • Biocompatibility screening is crucial for evaluating the safety of materials and substances in biological systems.
  • Current methods for assessing biocompatibility can be time-consuming and lack sensitivity.
  • Distinguishing between different modes of cell death (apoptosis vs. necrosis) is important for accurate toxicological assessment.

Purpose of the Study:

  • To investigate the utility of adenosine triphosphate (ATP) bioluminescence for rapid and sensitive biocompatibility screening.
  • To evaluate the potential of this method for determining proliferative and cytotoxic effects.
  • To explore the extension of ATP bioluminescence for differentiating between apoptotic and necrotic cell death.

Main Methods:

  • Utilized adenosine triphosphate (ATP) bioluminescence assays to measure cellular metabolic activity.

Related Experiment Videos

  • Implemented an additional measurement step for adenosine diphosphate (ADP) levels.
  • Assessed the correlation between bioluminescence signals and known cytotoxic/proliferative effects.

    • Main Results:

    • ATP bioluminescence demonstrated high sensitivity and speed for biocompatibility screening.
    • The method effectively determined proliferative and cytotoxic effects of tested substances.
    • The addition of ADP measurement allowed for the discrimination of cell death mechanisms (apoptosis vs. necrosis).

    Conclusions:

    • Adenosine triphosphate bioluminescence is a valuable tool for rapid and sensitive biocompatibility assessment.
    • This technology can accurately identify proliferative and cytotoxic responses.
    • The combined ATP/ADP bioluminescence approach provides a comprehensive method for analyzing cell death pathways.